Pulmokine
Larry Zisman has extensive experience in the biopharmaceutical industry, holding positions such as Senior Director at Gossamer Bio Inc., CEO at Pulmokine Inc., VP Cardiovascular Research at Cytopia Inc., and Director at Myomatrix Therapeutics. Larry is dedicated to developing new treatments for orphan diseases such as PAH and pulmonary fibrosis.
This person is not in any offices